Chemometec A/S (CHEMM.CO) stock: key figures, P/E, revenue and dividend

Health Care · Denmark · ISIN DK0060055861

Price
610.00 DKK
Market cap
10.62 bn DKK
P/E (2026)
–
P/S (2026)
20.77
Dividend yield
0.00 %
Net margin
39.49 %
Return on equity (ROE)
27.82 %
Return on assets (ROA)
23.44 %

Chemometec A/S financials

Fiscal year20252026
Revenue495.00 m DKK511.06 m DKK
Gross profit465.00 m DKK485.99 m DKK
Operating income236.52 m DKK251.00 m DKK
EBIT247.00 m DKK–
Net income186.00 m DKK201.84 m DKK
Diluted EPS – continuing operations10.71 DKK–

Full history since 2004, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Chemometec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.